Molecular Diagnostics Point of Care Market Share, Size, Revenue, Latest Trends, CAGR Status, Growth Opportunities and Forecast

Molecular Diagnostics Point of Care Market

In 2027, it is anticipated that the global market for molecular diagnostics at the point of care would grow to $4.84 billion. Continued research and development to miniaturise tests with molecular diagnostics that enable more patient testing with higher precision and quicker turnaround times are the primary reasons that are anticipated to strengthen the high growth potential for POC MDx products.

Over the predicted period, rising need in non-laboratory settings such pharmacy clinics, medical offices, and home care tests—which are, by definition, portable and safe—would probably result in lower market demand. CLIA tests are anticipated to see a rise in demand. Governments of developing nations and a handful of other sizable international organisations actively promote and finance ongoing research and development.

Additionally, over the past ten years, a wide range of point-of-care testing technologies have developed quickly with the aim of expanding their potential market to a wider range of medical faculties. These technologies were initially concentrated on the screening, monitoring, and diagnosis of infectious diseases in low-income developing countries. As a result, haematological testing, oncological testing, and cardiological monitoring are now offered or being developed.

Recent advancements in genetic sequencing and microfluidics technology have paved the way for the development of low-cost, extremely accurate, and quick test platforms that can be employed as POC systems. This is a significant aspect that adds significantly to the PoC molecular diagnostics market’s well-funded, high growth potential.

Get PDF Sample Report + All Related Table and Graphs @ https://www.emergenresearch.com/request-sample/11

Key Highlights of Report

Due to the existence of numerous large corporations with a diverse product offering, POC MDx research is utilised in the majority of consumer incomes for infectious diseases.

The increased incidence of infectious diseases in both developed and emerging nations is another reason for this section’s predominance.

PCR-based POC studies are the industry segment that generates the most sales. There are several reasons for the category to increase thanks to the widespread usage of PCR-based technology for PCR products for molecular diagnosis and marketing.

The most developed medical system in the world, as well as public and private efforts in R&D to advance MDx POC testing, made North America the greatest region in terms of revenue generation.

Becton Dickinson will expand the MDx diagnostic acquisition to the sites of care starting in May 2020.

Abbott Laboratories, Bayer Healthcare, Roche Diagnostics, Bio-Rad Laboratories, Danaher Corporation, BioMerieux, Dako, Abaxis Inc., OraSure Technologies Inc., and Nipro Diagnostics are a few of the major competitors in the market.

For the purpose of this report, Emergen Research has segmented into the global Molecular Diagnostics Point of Care Market on the basis of Test Location, Technology, Application, End-Use, and region:

Test Location Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

  • Over-the-Counter (OTC)
  • PoC

Technology Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

  • PCR-based
  • Genetic Sequencing-based
  • Hybridization-based
  • Microarray-based

Application Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

  • Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Others

End-Use Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

  • Decentralized Labs
  • Hospitals
  • Homecare
  • Assisted Living Healthcare Facilities
  • Others

Regional Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

  • North America
    1. S.
    2. Canada
  • Europe
    1. UK
    2. Germany
    3. France
    4. BENELUX
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

Find More Competitor in TOC with Profile Overview Share Growth Analysis @ https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Title: Spherical Graphite Market| Iot Medical Devices Market

Latest Report : Calcite Market| Healthcare Supply Chain Management Market

You may also like...

Leave a Reply

Your email address will not be published.